In CRC, loss of N‐Myc downstream‐regulated gene 4 (Ndrg4) function in organoid models triggered neuronal secretion of tumor-promoting factors, including nidogen 1 and fibulin 2, identifying novel therapeutic targets within neurogenic signaling pathways [387]. Here, FBLN2 is linked to neoplasm.